Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

1.0K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
1.0K
Vaccinations01:51

Vaccinations

47.3K
Overview
47.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

535
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
535
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

696
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
696
Cancer Vaccines01:30

Cancer Vaccines

581
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
Surface Membrane Barriers01:18

Surface Membrane Barriers

1.8K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging cDC1 biology and function for enhanced immunotherapy.

The Journal of experimental medicine·2026
Same author

Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T-cell responses and anti-tumor immunity by targeting conventional type 1 dendritic cells.

Immunology and cell biology·2025
Same author

The source of dietary fat influences anti-tumour immunity in obese mice.

Nature metabolism·2025
Same author

Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion.

Science advances·2025
Same author

Rational design of polymer-based particulate vaccine adjuvants.

European journal of immunology·2023
Same author

Immunostimulatory nanoparticles go viral.

Nature materials·2023

Related Experiment Video

Updated: Oct 26, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.2K

Mucosal vaccines - fortifying the frontiers.

Ed C Lavelle1, Ross W Ward2

  • 1Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. lavellee@tcd.ie.

Nature Reviews. Immunology
|July 27, 2021
PubMed
Summary

Mucosal vaccines can prevent infections by inducing immunity at pathogen entry sites. Advances in mucosal adjuvant and delivery strategies are crucial for developing new vaccines against diseases like SARS-CoV-2 and cancer.

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.0K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K

Related Experiment Videos

Last Updated: Oct 26, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.2K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.0K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Disease

Background:

  • Mucosal vaccines aim to induce protective immunity at pathogen entry sites, preventing infection establishment.
  • Current licensed mucosal vaccines are limited to live attenuated and inactivated whole-cell preparations.
  • Injectable vaccine advancements (subunit, RNA, DNA) have not yet translated to mucosal applications.

Purpose of the Study:

  • To highlight the potential of mucosal vaccines in preventing infections at their primary sites.
  • To identify key areas for advancing mucosal vaccine development, including adjuvants and delivery systems.
  • To explore how a deeper understanding of mucosal immunity mechanisms can inform rational vaccine design.

Main Methods:

  • Review of current understanding of innate and adaptive mucosal immunity.
  • Analysis of mechanisms regulating mucosal immune responses and inter-site crosstalk.
  • Identification of key cellular targets within mucosal tissues for vaccine design.

Main Results:

  • Significant progress in understanding mucosal immunity mechanisms provides insights for adjuvant design.
  • Knowledge of mucosal antigen-presenting cells, innate lymphoid cells, and resident memory cells offers vaccine targets.
  • Potential to leverage new vaccine technologies for rational mucosal vaccine development.

Conclusions:

  • Developing safe and effective mucosal adjuvants, alongside innovative antigen delivery, is essential for advancing mucosal vaccines.
  • Understanding mucosal immunity mechanisms and cellular targets can guide the design of next-generation vaccines.
  • These advancements hold promise for pathogens like SARS-CoV-2 and for cancer vaccines.